Antimicrobial activity and molecular docking studies of a novel anthraquinone from a marine-derived fungus Aspergillus versicolor.
Weiyi WangRuixuan ChenZhuhua LuoWei WangJianming ChenPublished in: Natural product research (2017)
A novel anthraquinone, 2-(dimethoxymethyl)-1-hydroxyanthracene-9,10-dione (1), together with nine known compounds (2-10), were isolated from the fermentation of Aspergillus versicolor derived from deep sea sediment. Their structures were established through spectroscopic methods. Compound 1 exhibited strong inhibitory activities against MRSA ATCC 43300 and MRSA CGMCC 1.12409 (with MIC values of 3.9 and 7.8 μg/mL respectively) and moderate activities against tested strains of Vibrio (with MIC values ranging from 15.6 to 62.5 μg/mL). Compound 1 was subjected to molecular docking studies for inhibition of topoisomerase IV and AmpC β-lactamase enzymes indicating its usefulness as antimicrobial agent.
Keyphrases
- molecular docking
- staphylococcus aureus
- methicillin resistant staphylococcus aureus
- escherichia coli
- molecular dynamics simulations
- case control
- biofilm formation
- heavy metals
- cell wall
- multidrug resistant
- high resolution
- high intensity
- klebsiella pneumoniae
- gram negative
- risk assessment
- polycyclic aromatic hydrocarbons
- mass spectrometry
- pseudomonas aeruginosa
- candida albicans